Cyclosporin B Inhibitor

Cyclosporin B is an immunosuppressant that has revolutionized organ transplantation through its use in the prevention of graft rejection. Cyclosporin B displays antiviral properties, inhibiting the entry of hepatitis B into hepatocytes. Cyclosporin B also inhibits RANKL-induced TRAP phosphatase activity, inducing apoptosis in osteoclasts. Cyclosporin B is a derivative of cyclosporin A that exhibits significantly less immunosuppressive activity.

Jansen Of Lorkeers SJ, Hart E, Tang XL, Chamuleau ME, Doevendans PA, Bolli R, Chamuleau SA. Cyclosporin in cell therapy for cardiac regeneration. J Cardiovasc Transl Res. 2014 Jul;7(5):475-82. doi: 10.1007/s12265-014-9570-8. Epub 2014 May 16. Review. PubMed PMID: 24831573; PubMed Central PMCID: PMC4435776.
Penninga L, Penninga EI, Moller CH, Iversen M, Steinbruchel DA, Gluud C. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. Cochrane Database Syst Rev. 2013 May 31;(5):CD008817. doi: 10.1002/14651858.CD008817.pub2. Review. PubMed PMID: 23728681.
Cheng M. Hartmann Stahelin (1925-2011) and the contested history of cyclosporin A. Clin Transplant. 2013 May-Jun;27(3):326-9. doi: 10.1111/ctr.12072. Epub 2013 Jan 20. Review. PubMed PMID: 23331048.
Yilmaz M, Eskazan AE, Unsal A, Taninmis H, Kara E, Cetiner M, Ferhanoglu B. Cyclosporin A therapy on idiopathic thrombotic thrombocytopenic purpura in the relapse setting: two case reports and a review of the literature. Transfusion. 2013 Jul;53(7):1586-93. doi: 10.1111/j.1537-2995.2012.03944.x. Epub 2012 Nov 1. Review. PubMed PMID: 23121663.

Small volumes of Cyclosporin B, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5756242 is an inhibitor targeting Cyclosporin B.